The chemical class referred to as TGTP Inhibitors encompasses a diverse range of compounds that indirectly influence the function of TGTP, a protein whose specific characteristics and pathways are not comprehensively understood. This class includes inhibitors that target various aspects of cellular signaling and GTPase-related processes, which are speculated to be associated with TGTP's function. These inhibitors operate by modulating the activity of enzymes and signaling pathways that are likely to intersect with the functional landscape of TGTP. By impacting these pathways, these chemicals can indirectly influence the activity and regulatory mechanisms in which TGTP may be involved.
For instance, inhibitors like Brefeldin A and SecinH3 target protein transport and ARF GTPase signaling, respectively. Their actions on these pathways can lead to alterations in cellular processes that are potentially linked to TGTP's function. Brefeldin A's role in disrupting protein transport can have cascading effects on various GTPase activities, including those potentially regulated or influenced by TGTP. SecinH3, by modulating ARF GTPase signaling, can indirectly affect the broader GTPase-related processes within which TGTP may operate. Similarly, compounds like NSC23766 and ML141, which specifically inhibit Rac1 and Cdc42 GTPases, respectively, demonstrate the potential to modulate signaling pathways and cellular activities related to GTPase function. This modulation can extend to the functional sphere of TGTP, given the interconnected nature of GTPase signaling pathways.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Inhibe le transport des protéines en interférant avec la fonction de l'appareil de Golgi, affectant potentiellement les processus liés aux GTPases. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
Inhibe spécifiquement la GTPase Rac1, affectant potentiellement les voies liées à l'activité de la GTPase. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $273.00 | 6 | |
Inhibe les cytohésines, affectant la signalisation de la GTPase ARF, ce qui pourrait avoir un impact sur les processus liés au TGTP. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $100.00 $408.00 | 6 | |
Agent antifibrotique agissant indirectement sur le TGF-Beta, utilisé pour la fibrose pulmonaire idiopathique. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibiteur de mTOR, affectant potentiellement la fonction des cellules T et les activités GTPase associées. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $86.00 | 3 | |
Un inhibiteur de la kinase TGFBR1 étudié en vue d'une thérapie potentielle contre le cancer. | ||||||